RA 10918 Flashcards
Philippine Pharmacy Act
RA 10918
RA 10918
Philippine Pharmacy Act
RA 8981
PRC Modernization Act of 2000
set of functions that would require the unique expertise of the pharmacist, the absence of which would impact on health and safety
Activities Exclusive to Pharmacists
- cervical cancer, flu (influenza), pneumococcal, other pre-exposure prophylactic vaccines to be administered to patients aged eighteen (18) years and above, and such other vaccines, as may be defined by the Department of Health (DOH) in an administrative issuance
adult vaccine
- pharmaceutical product unfit for human consumption
- as well as those provided for in R. A. No. 3720, otherwise known as the “Food, Drug and Cosmetic Act”, as amended, and R. A. No. 9711, known as the “Food and Drug Administration Act of 2009”
Adulterated/Deteriorated Pharmaceutical Product
noxious and unintended reaction to a drug which occurs at doses normally used in humans for the prophylaxis, diagnosis or treatment of disease or for the modification of physiologic function
Adverse Drug Reaction
- pharmaceutical product used for therapeutic or for in vivo diagnostic purposes, such as vaccines, sera, and drugs derived from life forms by biotechnology.
- include proteins, nucleic acids, or living microorganisms where the virulence is reduced and are used for therapeutic or for in vivo diagnostic purposes
biopharmaceutical
proprietary name given by the manufacturer to distinguish its product from those of competitors
brand name
method of secret writing or use of characteristic style or symbol by substituting other letter/s or character/s for the letter/s intended for the purpose of misleading the consumer
cipher, code, secret key
- patient care provided by a pharmacist, through pharmacologic and non-pharmacologic strategies, that promote the appropriate selection and utilization of medication to optimize individualized therapeutic outcomes, prevent diseases or achieve wellness;
clinical pharmacy service
- sum of processes performed by a pharmacist in drug preparation including the calculations, mixing, assembling, packaging, or labeling of a drug:
(1) as the result of a prescription or drug order by a physician, dentist or veterinarian, or
(2) for the purpose of, or in relation to, research, teaching, or chemical analysis;
compounding
- inculcation of advanced knowledge, skills, and ethical values in a post-licensure specialized or in an inter- or multi-disciplinary field of study for assimilation into professional practice, self-directed research, and/or lifelong learning;
continuing professional development
- substance or preparation intended to be placed in contact with the various external parts of the human body or with the teeth and the mucous membranes of the oral cavity, with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance and/or correcting body odor, and/or protecting the body or keeping them in good condition, as defined under R. A. No. 9711;
cosmetics
- pharmaceutical product which does not contain the amounts as claimed; with wrong ingredients; without active ingredients; or with insufficient quantity of active ingredients which result in the reduction of the products’ safety, efficacy, quality, strength or purity.
- product that is deliberately and fraudulently mislabeled with respect to identity and/or source or with fake packaging, and can apply to both branded and generic products, including the following:
counterfeit pharmaceutical product
refers to those listed in the:
(1) Schedules annexed to the 1961 Single Convention on Narcotic Drugs, as amended by the 1972 Protocol;
(2) Schedules annexed to the 1971 Single Convention on Psychotropic Substances;
(3) Annex of R. A. No. 9165, otherwise known as the “Comprehensive Dangerous Drugs Act of 2002”, and its amendments;
dangerous drug
- sum of processes performed by a pharmacist from reading, validating, and interpreting prescriptions; preparing; packaging; labelling; record keeping; dose calculations; and counselling or giving information, in relation to the sale, transfer or provision of pharmaceutical products, with or without a prescription or medication order;
dispensing
- pharmaceutical product that pertains to chemical compound/s or biological substance/s, other than food, intended for use in the treatment, prevention, or diagnosis of disease in humans or animals, including the following:
drug
herbal or traditional drugs as defined in R. A. No. ______, known as the ___________________________
RA 9502
Universally Accessible, Cheaper and Quality Medicines Act
- any drug or pharmaceutical establishment that imports or exports raw materials, active ingredients and/or finished drug products for its own use or for wholesale distribution to other drug or pharmaceutical establishments or outlets. If the distributor/importer/exporter/wholesaler sells to the general public, it shall be considered a retailer;
Drug Distributor/Importer/Exporter/Wholesaler
- any activity in response to a drug information request or query from healthcare professionals, organizations, committees, patients and other individuals with the goal of providing carefully evaluated, evidence-based drug information and recommendation to support medication use practice, enhance quality of patient care, improve patient outcomes and ensure prudent use of resources
Drug Information Service
- a life-threatening situation where a patient needs immediate medical attention and treatment, including the occurrence of epidemic or natural calamities
emergency case
- end date when the manufacturer can guarantee that a product possesses its claimed potency, efficacy, quality, and safety, after which its sale or distribution is prohibited
expiration date
act of dispensing or providing medicines in accordance with a prescription or medication order;
filling
- processed food product intended to supplement the diet that bears or contains 1 or more of the following dietary ingredients: vitamins, minerals, herbs, or other botanicals, amino acids, and dietary substances
- usually in the form of capsules, tablets, liquids, gels, powders, or pills and not represented for use as a conventional food or as the sole item of a meal or diet or replacement of drugs and medicines, as defined under R. A. No. 9711;
Food/Dietary Supplement
scientifically and internationally recognized name of the active ingredients, as approved by the FDA pursuant to R. A. No. 6675, otherwise known as the “Generics Act of 1988”
Generic Name
international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects
Good Clinical Practice (GCP)
that part of quality assurance which ensures that the quality of a pharmaceutical product is maintained through adequate control throughout the numerous activities which occur during the distribution process
Good Distribution Practice (GDP)
quality system concerned with the organizational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported;
Good Laboratory Practice (GLP)
- system of quality assurance aimed at ensuring that products are consistently manufactured to a quality appropriate for their intended use.
- concerned with both manufacturing and quality control processes and procedures;
Good Manufacturing Practice (GMP)
practice of pharmacy that responds to the needs of the people who use the pharmacists’ services to provide optimal evidence-based care;
Good Pharmacy Practice (GPP)
practice of regulation that should be clear, simple and practical for users through identified policy objectives, consistent with international standards in a sound legal and empirical basis which produces benefits that justify and minimize costs and market distortions, in consideration of its effects across society and taking into account economic, environmental and social factors
Good Regulatory Practice (GRP)
that part of quality assurance which ensures that the quality of a pharmaceutical product is maintained through adequate control throughout its storage
Good Storage Practice (GSP)
that part of quality assurance which ensures that the quality of a pharmaceutical product is maintained through adequate control throughout the warehousing
Good Warehousing Practice (GWP)
activities or range of pharmacy operations from selecting, ordering, delivery, transport, receipt, inventory of stocks, to arranging and display, compounding, storage, dispensing, provision of medication and health information to patients and/or healthcare providers and selling of pharmaceutical products, including waste disposal;
Handling of Pharmaceutical Products